Primary Immunodeficiency Disorders Market

Primary Immunodeficiency Disorders Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

215

Base Year:

2023

Nov - 2024

Format:

Report Code:

VMR-3149

Segments Covered

By Disease Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Others
By Treatment Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell/Bone Marrow Transplantation, Gene Therapy, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 7.08 Billion
Revenue 2032:	USD 12.17 Billion
Revenue CAGR (2024 - 2032):	6.2%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Primary Immunodeficiency Disorders Market - Segment Analysis
1. Overview
2. Global Primary Immunodeficiency Disorders Market, 2016 - 2028 (USD Million)
3. Global Primary Immunodeficiency Disorders Market - by Disease
  1. By Antibody Deficiency
  2. By Cellular Immunodeficiency
  3. By Innate Immune Disorders
  4. By Others
4. Global Primary Immunodeficiency Disorders Market - by Treatment
  1. By Immunoglobulin Replacement Therapy
  2. By Antibiotic Therapy
  3. By Stem Cell/Bone Marrow Transplantation
  4. By Gene Therapy
  5. By Others
5. Global Primary Immunodeficiency Disorders Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
6. Market comparative analysis
North America Primary Immunodeficiency Disorders Market - Segment Analysis
1. Overview
2. North America Primary Immunodeficiency Disorders Market, 2016 - 2028 (USD Million)
3. North America Primary Immunodeficiency Disorders Market, by Disease
  1. By Antibody Deficiency
  2. By Cellular Immunodeficiency
  3. By Innate Immune Disorders
  4. By Others
4. North America Primary Immunodeficiency Disorders Market, by Treatment
  1. By Immunoglobulin Replacement Therapy
  2. By Antibiotic Therapy
  3. By Stem Cell/Bone Marrow Transplantation
  4. By Gene Therapy
  5. By Others
5. North America Primary Immunodeficiency Disorders Market, by Country
  1. U.S.
    1. U.S. Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. U.S. Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  2. Canada
    1. Canada Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Canada Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  3. Mexico
    1. Mexico Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Mexico Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
Europe Primary Immunodeficiency Disorders Market - Segment Analysis
1. Overview
2. Europe Primary Immunodeficiency Disorders Market, 2016 - 2028 (USD Million)
3. Europe Primary Immunodeficiency Disorders Market, by Disease
  1. By Antibody Deficiency
  2. By Cellular Immunodeficiency
  3. By Innate Immune Disorders
  4. By Others
4. Europe Primary Immunodeficiency Disorders Market, by Treatment
  1. By Immunoglobulin Replacement Therapy
  2. By Antibiotic Therapy
  3. By Stem Cell/Bone Marrow Transplantation
  4. By Gene Therapy
  5. By Others
5. Europe Primary Immunodeficiency Disorders Market, by Country
  1. Germany
    1. Germany Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Germany Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  2. UK
    1. UK Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. UK Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  3. France
    1. France Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. France Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  4. Spain
    1. Spain Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Spain Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  5. Italy
    1. Italy Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Italy Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  6. BENELUX
    1. BENELUX Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. BENELUX Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  7. Rest of Europe
    1. Rest Of Europe Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Rest Of Europe Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
Asia Pacific Primary Immunodeficiency Disorders Market - Segment Analysis
1. Overview
2. Asia Pacific Primary Immunodeficiency Disorders Market, 2016 - 2028 (USD Million)
3. Asia Pacific Primary Immunodeficiency Disorders Market, by Disease
  1. By Antibody Deficiency
  2. By Cellular Immunodeficiency
  3. By Innate Immune Disorders
  4. By Others
4. Asia Pacific Primary Immunodeficiency Disorders Market, by Treatment
  1. By Immunoglobulin Replacement Therapy
  2. By Antibiotic Therapy
  3. By Stem Cell/Bone Marrow Transplantation
  4. By Gene Therapy
  5. By Others
5. Asia Pacific Primary Immunodeficiency Disorders Market, by Country
  1. China
    1. China Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. China Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  2. Japan
    1. Japan Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Japan Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  3. India
    1. India Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. India Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  4. South Korea
    1. South Korea Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. South Korea Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  5. South East Asia
    1. South East Asia Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. South East Asia Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Rest of Asia Pacific Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
Latin America Primary Immunodeficiency Disorders Market - Segment Analysis
1. Overview
2. Latin America Primary Immunodeficiency Disorders Market, 2016 - 2028 (USD Million)
3. Latin America Primary Immunodeficiency Disorders Market, by Disease
  1. By Antibody Deficiency
  2. By Cellular Immunodeficiency
  3. By Innate Immune Disorders
  4. By Others
4. Latin America Primary Immunodeficiency Disorders Market, by Treatment
  1. By Immunoglobulin Replacement Therapy
  2. By Antibiotic Therapy
  3. By Stem Cell/Bone Marrow Transplantation
  4. By Gene Therapy
  5. By Others
5. Latin America Primary Immunodeficiency Disorders Market, by Country
  1. Brazil
    1. Brazil Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Brazil Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  2. Argentina
    1. Argentina Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Argentina Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  3. Rest of Latin America
    1. Rest of Latin America Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Rest of Latin America Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
Middle East & Africa Primary Immunodeficiency Disorders Market - Segment Analysis
1. Overview
2. Middle East & Africa Primary Immunodeficiency Disorders Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Primary Immunodeficiency Disorders Market, by Disease
  1. By Antibody Deficiency
  2. By Cellular Immunodeficiency
  3. By Innate Immune Disorders
  4. By Others
4. Middle East & Africa Primary Immunodeficiency Disorders Market, by Treatment
  1. By Immunoglobulin Replacement Therapy
  2. By Antibiotic Therapy
  3. By Stem Cell/Bone Marrow Transplantation
  4. By Gene Therapy
  5. By Others
5. Middle East & Africa Primary Immunodeficiency Disorders Market, by Country
  1. GCC Countries
    1. GCC Countries Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. GCC Countries Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  2. South Africa
    1. South Africa Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. South Africa Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Primary Immunodeficiency Disorders Market, By Disease
      1. By Antibody Deficiency
      2. By Cellular Immunodeficiency
      3. By Innate Immune Disorders
      4. By Others
    2. Rest of Middle East & Africa Primary Immunodeficiency Disorders Market, By Treatment
      1. By Immunoglobulin Replacement Therapy
      2. By Antibiotic Therapy
      3. By Stem Cell/Bone Marrow Transplantation
      4. By Gene Therapy
      5. By Others
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Abbott Laboratories
2. Baxter International
3. CSL Behring
4. Takeda Pharmaceutical
5. Bio Products Laboratory
6. LFB
7. ADMA Biologics
8. Astellas Pharma
9. Octapharma
10. Biotest
11. Grifols
12. Kedrion Biopharma
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Primary Immunodeficiency Disorders in terms of revenue?

The global Primary Immunodeficiency Disorders valued at USD 7.08 Billion in 2023 and is expected to reach USD 12.17 Billion in 2032 growing at a CAGR of 6.2%.

Which are the prominent players in the market?

The prominent players in the market are Abbott Laboratories, Baxter International, CSL Behring, Takeda Pharmaceutical, Bio Products Laboratory, LFB, ADMA Biologics, Astellas Pharma, Octapharma, Biotest, Grifols, Kedrion Biopharma.

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 6.2% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Primary Immunodeficiency Disorders include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Primary Immunodeficiency Disorders in 2023.

Primary Immunodeficiency Disorders Market

Primary Immunodeficiency Disorders Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Primary Immunodeficiency Disorders in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Primary Immunodeficiency Disorders Market

Primary Immunodeficiency Disorders Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Primary Immunodeficiency Disorders in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Primary Immunodeficiency Disorders Market

Vantage Point Interactive Dashboard